Indian Gatifloxacin Exporters: Complete Supplier Ranking with Market Share — 54 Manufacturers (2026) — TransData Nexus

Q: Who is the largest gatifloxacin supplier from India?

AJANTA PHARMA LIMITED is the largest gatifloxacin exporter from India with a 47.7% market share and export value of $382.5K.

Q: How many gatifloxacin suppliers are there in India?

There are 54 active gatifloxacin exporters in India, collectively shipping $802.0K worth of gatifloxacin across 240 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top gatifloxacin suppliers from India?

The top 5 gatifloxacin suppliers from India — AJANTA PHARMA LIMITED, AUROLAB TRUST, DOSHI MEDICARE PRIVATE LIMITED, SUNWAYS (INDIA) PRIVATE LIMITED, SUNWAYS INDIA PRIVATE LIMITED — together control 84.2% of total gatifloxacin export value from India.

Suresh Sormare

Gatifloxacin

India Pharmaceutical Trade Intelligence

$802.0K54 Suppliers46 CountriesHS 30049099

ExportsIndia → IRAQ47.7%India → UGANDA26.0%

ImportsUNITED STATES → India$2.4M

#1 Supplier: AJANTA PHARMA #1 Buyer: SWASTIK PHARMACEUTICALS

Gatifloxacin Suppliers from India (2026) — 54 Exporters, $802.0K Market | TransData Nexus | TransData Nexus

Who Exports Gatifloxacin from India — 54 Suppliers Behind a $802.0K Market

India's gatifloxacin export market is supplied by 54 active exporters who collectively shipped $802.0K across 240 shipments. AJANTA PHARMA LIMITED leads with a 47.7% market share, followed by AUROLAB TRUST and DOSHI MEDICARE PRIVATE LIMITED. The top 5 suppliers together control 84.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published April 2026

India's Top Gatifloxacin Suppliers & Exporters — 54 manufacturers, $802.0K export market, top destinations and formulations — Gatifloxacin supplier data — 54 exporters · $802.0K market · 240 shipmentsTransData Nexus · Indian Customs Data

Top Gatifloxacin Exporters from India — Ranked by Export Value

AJANTA PHARMA LIMITED is the leading gatifloxacin exporter from India, holding a 47.7% share of the $802.0K market across 240 shipments from 54 exporters. The top 5 suppliers — AJANTA PHARMA LIMITED, AUROLAB TRUST, DOSHI MEDICARE PRIVATE LIMITED, SUNWAYS (INDIA) PRIVATE LIMITED, SUNWAYS INDIA PRIVATE LIMITED — collectively control 84.2% of total export value, indicating a highly concentrated market. Individual shares are: AJANTA PHARMA LIMITED (47.7%), AUROLAB TRUST (30.7%), DOSHI MEDICARE PRIVATE LIMITED (3.4%), SUNWAYS (INDIA) PRIVATE LIMITED (1.6%), SUNWAYS INDIA PRIVATE LIMITED (0.9%).

Top Gatifloxacin Exporters from India

Ranked by export value · 54 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Gatifloxacin Exporters from India — Ranked by Export Value. 54 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Gatifloxacin exporters

Certification and compliance status for top Gatifloxacin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
AJANTA PHARMA LIMITED	Not Listed	Yes	Yes	27	EU GMP certified as of September 9, 2013. (cms.mhra.gov.uk)
AUROLAB	Not Listed	Yes	Not Listed	Not verified	WHO-GMP certified for ophthalmic pharmaceuticals.
AUROBINDO PHARMA LIMITED	Approved	Not Listed	Yes	450+	Received EU GMP certification for biosimilars facility in November 2024.

TransData Nexus reviewed the regulatory standing of 3 leading Gatifloxacin exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Gatifloxacin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of Active Pharmaceutical Ingredients (APIs). The city's pharmaceutical ecosystem is bolstered by a robust infrastructure, including research institutions and industrial parks, which facilitate large-scale API manufacturing. While specific data on Gatifloxacin API production in Hyderabad is not readily available, the city's prominence in API manufacturing suggests a significant role in supplying raw materials for Gatifloxacin formulations.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a pivotal center for pharmaceutical formulations. Ajanta Pharma Limited, a leading exporter of Gatifloxacin, operates a state-of-the-art manufacturing facility in Dahej, Gujarat. This facility specializes in the production of tablets, capsules, and oral suspensions, and has received approvals from stringent regulatory authorities such as the US FDA and WHO. The presence of such advanced facilities underscores the region's capacity to produce high-quality Gatifloxacin formulations for both domestic and international markets.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Gatifloxacin exporters from India

December 2025

M&A

Ajanta Pharma Limited — Ajanta Pharma earmarks ₹1,000 crore for acquisitions

Ajanta Pharma has allocated over ₹1,000 crore for inorganic growth opportunities, focusing on therapy areas such as dermatology, pain management, nephrology, and gynaecology. The company aims to strengthen its portfolio through brand and product acquisitions, excluding manufacturing assets. - IMPACT: This strategic move may enhance Ajanta Pharma's product offerings, potentially increasing its Gatifloxacin exports.

Impact: This strategic move may enhance Ajanta Pharma's product offerings, potentially increasing its Gatifloxacin exports.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Gatifloxacin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which gatifloxacin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, AJANTA PHARMA LIMITED leads with 7 recorded shipments worth $382.5K. AUROLAB TRUST (30 shipments) and DOSHI MEDICARE PRIVATE LIMITED (8 shipments) are also established high-volume exporters.

Q How many gatifloxacin manufacturers are there in India?

India has 54 active gatifloxacin exporters with a combined export market of $802.0K across 240 shipments to 46 countries. The top 5 suppliers hold 84.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Gatifloxacin

Gatifloxacin

Who Exports Gatifloxacin from India — 54 Suppliers Behind a $802.0K Market

Top Gatifloxacin Exporters from India — Ranked by Export Value

Top Gatifloxacin Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Ajanta Pharma Limited — Ajanta Pharma earmarks ₹1,000 crore for acquisitions

Common Questions — Gatifloxacin Suppliers from India

Q Which gatifloxacin supplier from India is the most reliable for bulk orders?

Q How many gatifloxacin manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Q What is the typical price range for gatifloxacin from India?

Analysis Methodology